HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 14.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,457 shares of the company’s stock after selling 570 shares during the period. Mount Yale Investment Advisors LLC’s holdings in HealthEquity were worth $332,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. Wasatch Advisors LP increased its position in shares of HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after buying an additional 483,269 shares in the last quarter. State Street Corp increased its holdings in HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after acquiring an additional 23,613 shares in the last quarter. Clearbridge Investments LLC raised its position in HealthEquity by 1.9% during the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after acquiring an additional 43,491 shares during the period. Geode Capital Management LLC lifted its holdings in HealthEquity by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after purchasing an additional 15,145 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in shares of HealthEquity by 0.7% in the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock valued at $139,369,000 after purchasing an additional 11,659 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $108.80 on Thursday. The company’s 50-day moving average is $99.85 and its two-hundred day moving average is $88.02. The firm has a market capitalization of $9.43 billion, a price-to-earnings ratio of 99.82, a PEG ratio of 1.86 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $111.36.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the business earned $0.40 earnings per share. Analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling

In related news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares of the company’s stock, valued at $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

HQY has been the subject of several research analyst reports. Mizuho assumed coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. The Goldman Sachs Group assumed coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. BTIG Research increased their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Barrington Research lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.